Ennature Bio Pharma Ltd

$ENNATUREEquityBSE

Ennature Bio Pharma Ltd (ENNATURE) last reported results for the quarter ended Sep 2026, with sales of ₹78.46 crore and net profit of ₹4.89 crore. The stock last traded at ₹189, a market capitalisation of ₹420 crore, on a P/E of 55.2. Over the past 52 weeks the stock has ranged between ₹189 and ₹275. Figures are as of 17 Nov 2026 and are not real time.

Ennature Bio Pharma Ltd share price and key metrics

Current price
₹189
Market cap
₹420 cr
Stock P/E
55.2
ROE
%
ROCE
%
Dividend yield
0.00%
52w high / low
275/189

Metrics as of 17 Nov 2026. Not real time.

Track Ennature Bio Pharma Ltd

Cruxal reads every Ennature Bio Pharma Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Ennature Bio Pharma Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
%
3 Years
%
TTM
%
Compounded Profit Growth
10 Years
%
5 Years
%
3 Years
%
TTM
%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
%
1 Year
%
Return on Equity
10 Years
%
5 Years
%
3 Years
%
Last Year
%

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.